Newsmax (NMAX) debuted on the New York Stock Exchange on Monday, selling 7.5 million Class B shares at $10 apiece.
Shares surged 550% as intraday trading volume catapulted to over 4.68 million.
Corcept Therapeutics (CORT) shares soared 87% after the company said its phase 3 trial of relacorilant plus nab-paclitaxel to treat a type of ovarian cancer met its primary goal.
Piper Sandler raised Corcept's price target to $128 from $78 while maintaining its overweight rating.
More than 9.33 million shares of Corcept traded intraday compared with a daily average of about 1.01 million.
Newton Golf (NWTG) reported a year-over-year increase Monday of 817% in its Q4 net sales.
Shares advanced 35%, with intraday trading volume rising to over 47.5 million compared with a daily average of more than 1.16 million.
Price: 66.12, Change: +56.12, Percent Change: +561.24
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。